Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 37
Filter
1.
Rhinology ; 62(1): 13-22, 2024 Feb 01.
Article in English | MEDLINE | ID: mdl-37905726

ABSTRACT

BACKGROUND: The role of periostin in the pathophysiology of chronic rhinosinusitis with nasal polyposis (CRSwNP) has been debated in the literature, with several authors proposing periostin as a potential biomarker or theurapeutical target. However, the mechanisms regulating the systematic or local periostin production in both CRSwNP patients and controls remain elusive. METHODOLOGY: Any factors reported to affect periostin expression in polyp tissue samples, nasal mucosa samples, serum and nasal secretions were considered as primary outcomes in this systematic review. Interactions or synergistic effects between bias factors were considered as secondary outcomes. RESULTS: Eosinophilic CRSwNP, large polyp size and radiological severity were found to be high-risk, positive bias factors for periostin levels in polyp tissue samples, while the role of atopy and asthma has been debated. Immunotherapy and eosinophilic endotype were identified as biases for serum periostin measurements, while steroids and non-steroidal anti-inflammatory drug exacerbated respiratory disease remain of unclear risk. Bronchal asthma, eosinophilic endotype and immunotherapy have been reported to bias periostin measurements in nasal secretions. CONCLUSIONS: The relevant literature is extremely limited and little is actually known about the intrinsic or extrinsic factors affecting periostin measurements. The synthesis of the existing literature should be done with cautiousness.


Subject(s)
Asthma , Nasal Polyps , Rhinitis , Rhinosinusitis , Sinusitis , Humans , Asthma/complications , Chronic Disease , Nasal Polyps/complications , Periostin , Rhinitis/complications , Sinusitis/complications
2.
Eur Ann Otorhinolaryngol Head Neck Dis ; 140(3): 107-114, 2023 May.
Article in English | MEDLINE | ID: mdl-36088240

ABSTRACT

AIMS: The primary goal of the present study was to compare the pre- and post-stapedotomy elicitation and waveform characteristics of both air- and bone-conduction (AC-, BC-) cervical vestibular evoked myogenic potentials (cVEMPs) through an individualized approach. A possible association between audiological characteristics, such as AC- and BC- pure tone audiometry thresholds and air-bone gap and the production of cVEMPs before and after stapedotomy was also investigated. MATERIAL AND METHODS: Twenty-five ears were subjected to full audiological evaluation as well as AC- and BC-cVEMPs pre- and post-stapedotomy. Four subgroups were studied; consistently present/absent, post-operatively disappeared and restored cVEMPs. RESULTS: Post-stapedotomy changes in cVEMP elicitability did not reach significance for either AC-cVEMP (OR=5.41, 95% CI 0.88-33.36, P=0.06) or BC-cVEMP (OR=2.40, 95% CI 0.42-13.60, P=0.3). Normal or abnormal AC-cVEMPs were equally subject to post-operative changes (OR=1.95, 95% CI 0.32-12.01, P=0.5), as were BC-cVEMPs (OR=3.75, 95% CI 0.66-21.25, P=0.1). Neither the audiological characteristics nor the surgical outcome, in terms of ABG results, were relevant to the presence or absence of AC- and BC-cVEMPs before or after stapedotomy. CONCLUSIONS: The presumed changes brought to the sacculus by stapedotomy are minor and beyond the diagnostic abilities of either AC-cVEMPs or BC-cVEMPs, both in terms of cVEMPs elicitability and waveform characteristics. In individual cases, however, which may deserve further investigation, cVEMPs may reappear or disappear after stapedotomy probably following minor changes toward a lower or higher vestibular system resistance for pressure and sound transmission.


Subject(s)
Stapes Surgery , Vestibular Evoked Myogenic Potentials , Humans , Acoustic Stimulation/methods , Vestibular Evoked Myogenic Potentials/physiology , Bone Conduction/physiology , Neck , Stapes Surgery/adverse effects
3.
Rhinology ; 59(3): 245-257, 2021 Jun 01.
Article in English | MEDLINE | ID: mdl-33730750

ABSTRACT

BACKGROUND: The expression of metalloproteinases (MMPs) in chronic rhinosinusitis with nasal polyposis (CRSwNP) was reviewed in order to investigate their possible use as therapeutical targets and/or biomarkers. METHODOLOGY: The differences between CRSwNP and normal controls or CRS without NP, as well as the effects of various treatments on MMPs, tissue inhibitors of MMPs (TIMPs) and MMP/TIMP ratios were considered as primary outcomes. Additional factors reported to affect MMP expression levels were noted as secondary outcomes. Data regarding inflammatory subtypes, patients’ clinical characteristics, controls, laboratory method(s) and origin of samples were also pooled. Studies on 10 or fewer patients or on specimens other than nasal and serum were excluded. RESULTS: Forty-three studies were included. Tissue sample origin, allergic rhinitis, smoking, infection, medication intake and primary or recurrent disease should be considered as confounding factors for MMP levels. MMP-1 and -7 were consistently found to be significantly higher in CRSwNP patients than controls. CRSwNP endotypes with distinctly different inflammation patterns seem to present similar MMP-related remodelling patterns. CONCLUSIONS: The existing literature has revealed several population and methodology related confounding factors and remains inconclusive regarding the roles of MMPs in CRSwNP pathophysiology and their possible clinical usefulness as biomarkers and therapeutical targets.


Subject(s)
Nasal Polyps , Rhinitis , Sinusitis , Chronic Disease , Humans , Matrix Metalloproteinases , Nasal Mucosa/pathology , Nasal Polyps/pathology , Rhinitis/pathology , Sinusitis/pathology
4.
Acta Otorhinolaryngol Ital ; 38(2): 131-137, 2018 Apr.
Article in English | MEDLINE | ID: mdl-29967558

ABSTRACT

SUMMARY: Accumulating evidence seems to support an association between tinnitus and medial olivocochlear bundle (MOCB) dysfunction. Most studies use patient/control comparisons to support this correlation. The aim of this study was to investigate the hypothesis in a substantially different way and evaluate the roles of gender, age, frequency and tinnitus bilaterality as possible confounding factors. The population consisted of 78 normal hearing patients with chronic tinnitus, 28 normal hearing controls, 19 presbycousic tinnitus patients and 13 presbycousic controls (n = 276 ears). Mean suppression amplitudes of transient evoked otoacoustic emissions (TEOAEs) and distortion product OAEs (DPOAEs) by contralateral white noise (50 dB SPL) were computed. Mean suppression values < 1 dB SPL or < 2 dB SPL were validated as positive test results. Overall suppression (OS) values < 1 dB SPL were qualified as a diagnostic test of moderate positive predictive value for both DPOAEs and TEOAEs, while OS values < 2 dB SPL were found to be of large negative predictive value for DPOAEs and moderate for TEOAEs. Mean suppression values (for all frequencies, OS) are of higher diagnostic value than suppression values corresponding to either lower (1-2 kHz) or higher frequencies (2.8-4 kHz for TEOAEs and 2.8-6 kHz for DPOAEs). After excluding patients with unilateral tinnitus from the analysis, correlations were found to be stronger. Useful correlations were also attributed for all age groups < 61 years. In females, OAE suppression seems to have a stronger positive predictive value, while in males it seems to have a stronger negative predictive value. OAE-based assays of MOCB function as an objective diagnostic tool for subjective tinnitus might deserve further investigation. Tinnitus uni- or bi-laterality is a confounding factor, which probably confirms the observation that defective function of the MOCB usually applies to the contralateral ear as well. Gender is an additional confounding factor, while correlations can be verified for all age groups < 61 years old.


Subject(s)
Otoacoustic Emissions, Spontaneous , Tinnitus/diagnosis , Tinnitus/physiopathology , Adult , Age Factors , Female , Humans , Male , Middle Aged , Noise , Sex Factors , Young Adult
5.
Allergy ; 73(9): 1851-1859, 2018 Sep.
Article in English | MEDLINE | ID: mdl-29791010

ABSTRACT

BACKGROUND: The use of allergen immunotherapy (AIT) for allergic rhinitis and its clinical efficacy in clinical trials depends on the effective determination of pollen allergen exposure time periods. We evaluate pollen data from Germany to examine the new definitions on pollen season and peak pollen period start and end as proposed by the European Academy of Allergy and Clinical Immunology (EAACI) in a recently published Position Paper. The aim was to demonstrate the ability of these definitions to mirror symptom loads for grass and birch pollen-induced allergic rhinitis based on real-life data. METHODS: Data coming from four pollen monitoring stations in the Berlin and Brandenburg area in Germany and for 3 years (2014-2016) were used to investigate the correlation of season definitions, birch and grass pollen counts and total nasal symptom and mediation scores as reported by patients in "Patients Hay fever Diaries" (PHDs). After the identification of pollen periods on the basis of the EACCI criteria, a statistical analysis was employed, followed by a detailed graphical investigation. RESULTS: The analysis revealed that the definitions of pollen season as well as peak pollen period start and end as proposed by the EAACI are correlated to symptom loads for grass and birch pollen-induced allergic rhinitis reported by patients in PHDs. CONCLUSION: Based on our analysis, the validity of the EAACI definitions on pollen season is confirmed. Their use is recommended in future clinical trials on AIT as well as in daily routine for optimal patient care.


Subject(s)
Allergens/immunology , Betula/adverse effects , Poaceae/adverse effects , Pollen/immunology , Rhinitis, Allergic/diagnosis , Rhinitis, Allergic/immunology , Disease Management , Female , Geography , Germany/epidemiology , Humans , Male , Public Health Surveillance , Rhinitis, Allergic/epidemiology , Rhinitis, Allergic/therapy , Seasons
6.
Curr Top Behav Neurosci ; 36: 75-105, 2018.
Article in English | MEDLINE | ID: mdl-28238186

ABSTRACT

Hallucinogens evoke sensory, perceptual, affective, and cognitive effects that may be useful to understand the neurobiological basis of mood and psychotic disorders. The present chapter reviews preclinical research carried out in recent years in order to better understand the action of psychotomimetic agents such as the noncompetitive NMDA receptor (NMDA-R) antagonists and serotonergic hallucinogens. Our studies have focused on the mechanisms through which these agents alter cortical activity. Noncompetitive NMDA-R antagonists, such as phencyclidine (PCP) and MK-801 (dizocilpine), as well as the serotonergic hallucinogens DOI and 5-MeO-DMT, produce similar effects on cellular and population activity in prefrontal cortex (PFC); these effects include alterations of pyramidal neuron discharge (with an overall increase in firing), as well as a marked attenuation of the low frequency oscillations (0.2-4 Hz) to which neuronal discharge is coupled in anesthetized rodents. PCP increases c-fos expression in excitatory neurons from various cortical and subcortical areas, particularly the thalamus. This effect of PCP involves the preferential blockade of NMDA-R on GABAergic neurons of the reticular nucleus of the thalamus, which provides feedforward inhibition to the rest of thalamic nuclei. It is still unknown whether serotonergic hallucinogens also affect thalamocortical networks. However, when examined, similar alterations in other cortical areas, such as the primary visual cortex (V1), have been observed, suggesting that these agents affect cortical activity in sensory and associative areas. Interestingly, the disruption of PFC activity induced by PCP, DOI and 5-MeO-DMT is reversed by classical and atypical antipsychotic drugs. This effect suggests a possible link between the mechanisms underlying the disruption of perception by multiple classes of hallucinogenic agents and the therapeutic efficacy of antipsychotic agents.


Subject(s)
Hallucinogens/pharmacology , Neurons/drug effects , Animals , Humans , Receptors, GABA/drug effects , Receptors, N-Methyl-D-Aspartate/drug effects , Signal Transduction/drug effects
8.
Anaesth Intensive Care ; 45(5): 581-588, 2017 09.
Article in English | MEDLINE | ID: mdl-28911287

ABSTRACT

This study aimed to assess the effects of sugammadex and neostigmine/atropine on postoperative cognitive dysfunction (POCD) in adult patients after elective surgery. A randomised, double-blind controlled trial was carried out on 160 American Society of Anesthesiologists physical status I to III patients who were >40 years. The Mini-Mental State Evaluation, clock-drawing test and the Isaacs Set test were used to assess cognitive function at three timepoints: 1) preoperatively, 2) one hour postoperatively, and 3) at discharge. The anaesthetic protocol was the same for all patients, except for the neuromuscular block reversal, which was administered by random allocation using either sugammadex or neostigmine/atropine after the reappearance of T2 in the train-of-four sequence. POCD was defined as a decline ≥1 standard deviation in ≥2 cognitive tests. The incidence of POCD was similar in both groups at one hour postoperatively and at discharge (28% and 10%, in the neostigmine group, 23% and 5.4% in the sugammadex group, P=0.55 and 0.27 respectively). In relation to individual tests, a significant decline of clock-drawing test in the neostigmine group was observed at one hour postoperatively and at discharge. For the Isaacs Set test, a greater decline was found in the sugammadex group. These findings suggest that there are no clinically important differences in the incidence of POCD after neostigmine or sugammadex administration.


Subject(s)
Atropine/administration & dosage , Cognitive Dysfunction/epidemiology , Neostigmine/administration & dosage , Postoperative Complications/epidemiology , gamma-Cyclodextrins/administration & dosage , Adult , Cognitive Dysfunction/etiology , Double-Blind Method , Elective Surgical Procedures , Female , Humans , Male , Middle Aged , Muscarinic Antagonists/administration & dosage , Neuromuscular Blockade/methods , Parasympathomimetics/administration & dosage , Sugammadex
9.
Eur J Surg Oncol ; 43(1): 20-31, 2017 Jan.
Article in English | MEDLINE | ID: mdl-27320417

ABSTRACT

OBJECTIVE: The optimal treatment of patients with T3 laryngeal carcinoma is controversially challenged by open partial laryngectomies (OPL), transoral laser microsurgery (TLM) and radiation therapy alone (RT) or combined with chemotherapy (ChRT). Treatment guidelines, experts' opinions and clinical studies are highly contradictory. The aim of this study is to compare the primary outcomes of the available treatment methods and identify the sources of variance among studies. METHODS: A review of the literature published in the time period 2003-2015 was conducted via the PubMed database (www.pubmed.org) and Scopus database (www.scopus.com) with the search terms "T3 laryngeal squamous cell cancer treatment". Data from clinical studies involving patients with T3 laryngeal cancer (n > 10) subjected to TLM, OPL, ChRT or RT, were pooled. In the absence of controlled studies, prospective and retrospective clinical trials with minimum 5-year follow-up were acceptable, provided that they included a description of patient eligibility criteria, so as to exclude studies with serious selection bias. RESULTS: Literature lacks studies with homogenous populations regarding TNM staging, preoperative/postoperative treatment or anatomical subsite. This raises substantial controversies and prohibits the conduction of a meta-analysis. Data for qualitative analysis were pooled from 8 studies (n = 1226). OPL and TLM both offer patients high survival and organ preservation rates. Preoperative induction chemotherapy seems to significantly compromise overall survival. CONCLUSIONS: Multicenter studies referring to homogenous populations, at least regarding staging and anatomical subsite, are needed. No safe conclusions can be drawn given the heterogeneity in patient cohorts, study design and evaluation of results in the existing literature.


Subject(s)
Carcinoma, Squamous Cell/pathology , Carcinoma, Squamous Cell/therapy , Laryngeal Neoplasms/pathology , Laryngeal Neoplasms/therapy , Antineoplastic Agents/therapeutic use , Combined Modality Therapy , Humans , Laryngectomy , Laser Therapy/methods , Neoplasm Grading , Radiotherapy
10.
Int J Audiol ; 55(12): 775-781, 2016 12.
Article in English | MEDLINE | ID: mdl-27598848

ABSTRACT

OBJECTIVE: Normative otoacoustic emission (OAE) suppression values are currently lacking and the role of cochlear efferent innervation in tinnitus is controversial. The aim of this study was to investigate the association between tinnitus and medial olivocochlear bundle (MOCB) malfunction. Potential suppression amplitude cut-off criteria that could differentiate participants with tinnitus from those without were sought. DESIGN: Mean suppression amplitudes of transient evoked OAEs and distortion product OAEs by contralateral white noise (50 dBSL) were recorded. Six mean suppression amplitudes criteria were validated as possible cut-off points. STUDY SAMPLE: The population consisted of normal hearing (n = 78) or presbycusic adults (n = 19) with tinnitus or without (n = 28 and 13, respectively) chronic tinnitus (in total, n = 138 78 females/60males, aged 49 ± 14 years). RESULTS: Participants with mean suppression values lower than 0.5-1 dBSPL seem to present a high probability to report tinnitus (specificity 88-97%). On the other hand, participants with mean suppression values larger than 2-2.5dBSPL seem to present a high probability of the absence of tinnitus (sensitivity 87-99%). Correlations were stronger among participants with bilateral presence or absence of tinnitus. CONCLUSIONS: This study seem to confirm an association between tinnitus and low suppression amplitudes (<1 dBSPL), which might evolve into an objective examination tool, supplementary to conventional audiological testing.


Subject(s)
Acoustic Stimulation/methods , Cochlea/physiopathology , Hearing Tests/statistics & numerical data , Otoacoustic Emissions, Spontaneous/physiology , Perceptual Masking , Tinnitus/diagnosis , Adult , Female , Hearing Tests/methods , Humans , Male , Middle Aged , Noise , Probability , Reference Values , Sensitivity and Specificity , Tinnitus/physiopathology
11.
Insect Biochem Mol Biol ; 65: 91-9, 2015 Oct.
Article in English | MEDLINE | ID: mdl-26363294

ABSTRACT

Cyenopyrafen is a Mitochondrial Electron Transport Inhibitor (METI) acaricide with a novel mode of action at complex II, which has been recently developed for the control of the spider mite Tetranychus urticae, a pest of eminent importance globally. However, some populations of T. urticae are cross-resistant to this molecule, and cyenopyrafen resistance can be readily selected in the lab. The cytochrome P450s genes CYP392A11 and CYP392A12 have been strongly associated with the phenotype. We expressed the CYP392A11 and the CYP392A12 genes with T. urticae cytochrome P450 reductase (CPR) in Escherichia coli. CYP392A12 was expressed predominately as an inactive form, witnessed by a peak at P420, despite optimization efforts on expression conditions. However, expression of CYP392A11 produced a functional enzyme, with high activity and preference for the substrates Luciferin-ME EGE and ethoxycoumarin. CYP392A11 catalyses the conversion of cyenopyrafen to a hydroxylated analogue (kcat = 2.37 pmol/min/pmol P450), as well as the hydroxylation of fenpyroximate (kcat = 1.85 pmol/min/pmol P450). In addition, transgenic expression of CYP392A11 in Drosophila melanogaster, in conjunction with TuCPR, confers significant levels of fenpyroximate resistance. The overexpression of CYP392A11 in multi-resistant T. urticae strains, not previously exposed to cyenopyrafen, which had been indicated by microarray studies, was confirmed by qPCR, and it was correlated with significant levels of cyenopyrafen and fenpyroximate cross-resistance. The implications of our findings for insecticide resistance management strategies are discussed.


Subject(s)
Acaricides/metabolism , Acrylonitrile/analogs & derivatives , Arthropod Proteins/metabolism , Benzoates/metabolism , Cytochrome P-450 Enzyme System/metabolism , Inactivation, Metabolic , Pyrazoles/metabolism , Tetranychidae/drug effects , Acaricides/pharmacology , Acrylonitrile/metabolism , Acrylonitrile/pharmacology , Animals , Arthropod Proteins/genetics , Benzoates/pharmacology , Cytochrome P-450 Enzyme System/genetics , Drosophila melanogaster/drug effects , Insecticide Resistance , Pyrazoles/pharmacology , Tetranychidae/enzymology , Tetranychidae/genetics
12.
B-ENT ; 10(2): 121-5, 2014.
Article in English | MEDLINE | ID: mdl-25090810

ABSTRACT

INTRODUCTION: Chondrosarcomas of the larynx are usually slow-growing tumours. Their prognosis is reportedly unaffected by local tumour recurrence. Nevertheless, total laryngectomy is often performed in fear that resection of the posterior lamina of the cricoid cartilage may cause laryngeal collapse and stenosis. Transoral laser surgery (TLS) is not considered among the treatment options. This case report supports the feasibility of a radical yet organ- and function-preserving tumour excision using TLS. CASE REPORT: A female patient presented with dyspnoea due to an extensive low-grade laryngeal chondrosarcoma. TLS treatment involved total resection of the posterior lamina of the cricoid cartilage. The patient was decannulated 8 months later with normal swallowing and satisfactory voice quality, which allowed her to have a normal personal and social life. CONCLUSION: TLS excision of the posterior lamina of the cricoid cartilage seems to be a feasible and radical yet function- and organ-preserving technique with minimal morbidity.


Subject(s)
Chondrosarcoma/surgery , Cricoid Cartilage/surgery , Laryngeal Neoplasms/surgery , Laryngectomy/methods , Adult , Female , Humans , Mouth
13.
Insect Biochem Mol Biol ; 46: 43-53, 2014 Mar.
Article in English | MEDLINE | ID: mdl-24463358

ABSTRACT

Abamectin is one of the most important insecticides worldwide. It is used against major agricultural pests and insects of public health importance, as well as against endoparasites in animal health. Abamectin has been used successfully for the control of the spider mite Tetranychus urticae, a major agricultural pest with global distribution, an extremely diverse host range, and a remarkable ability to develop resistance against insecticides including abamectin. Target site resistance mutations may explain a large part of resistance, although genetic evidence and transcriptomic data indicated that additional mechanisms may also be implicated in the abamectin resistant phenotype. To investigate a functional link between cytochrome P450-mediated metabolism and abamectin resistance, we recombinantly expressed three cytochrome P450s (CYP392A16, CYP392D8 and CYP392D10) that have been associated with high levels of abamectin resistance in a resistant T. urticae strain isolated from Greece. CYP392A16 was expressed predominately in its P450 form however, both CYP392D8 and CYP392D10 were expressed predominately as P420, despite optimization efforts on expression conditions. CYP392A16 catalyses the hydroxylation of abamectin (Kcat=0.54 pmol/min/pmol P450; Km=45.9 µM), resulting in a substantially less toxic compound as confirmed by bioassays with the partially purified metabolite. However, CYP392A16 did not metabolize hexythiazox, clofentezine and bifenthrin, active ingredients that also showed reduced toxicity in the abamectin resistant strain. Among a number of fluorescent and luminescent substrates screened, Luciferin-ME EGE was preferentially metabolized by CYP392A16, and it may be a potential diagnostic probe for metabolic resistance detection and monitoring.


Subject(s)
Cytochrome P-450 Enzyme System/genetics , Drug Resistance/genetics , Ivermectin/analogs & derivatives , Tetranychidae/drug effects , Tetranychidae/genetics , Acaricides/metabolism , Acaricides/pharmacology , Animals , Arthropod Proteins/genetics , Arthropod Proteins/metabolism , Cytochrome P-450 Enzyme System/metabolism , Escherichia coli/genetics , Female , Gene Expression/drug effects , Ivermectin/metabolism , Ivermectin/pharmacology , Recombinant Proteins/genetics , Recombinant Proteins/metabolism , Tetranychidae/metabolism
14.
Int J Neuropsychopharmacol ; 16(10): 2145-63, 2013 Nov.
Article in English | MEDLINE | ID: mdl-23809188

ABSTRACT

Non-competitive NMDA receptor antagonists are widely used as pharmacological models of schizophrenia due to their ability to evoke the symptoms of the illness. Likewise, serotonergic hallucinogens, acting on 5-HT(2A) receptors, induce perceptual and behavioural alterations possibly related to psychotic symptoms. The neurobiological basis of these alterations is not fully elucidated. Data obtained in recent years revealed that the NMDA receptor antagonist phencyclidine (PCP) and the serotonergic hallucinogen 1-(2,5-dimethoxy-4-iodophenyl-2-aminopropane; DOI) produce a series of common actions in rodent prefrontal cortex (PFC) that may underlie psychotomimetic effects. Hence, both agents markedly disrupt PFC function by altering pyramidal neuron discharge (with an overall increase) and reducing the power of low frequency cortical oscillations (LFCO; < 4 Hz). In parallel, PCP increased c-fos expression in excitatory neurons of various cortical areas, the thalamus and other subcortical structures, such as the amygdala. Electrophysiological studies revealed that PCP altered similarly the function of the centromedial and mediodorsal nuclei of the thalamus, reciprocally connected with PFC, suggesting that its psychotomimetic properties are mediated by an alteration of thalamocortical activity (the effect of DOI was not examined in the thalamus). Interestingly, the observed effects were prevented or reversed by the antipsychotic drugs clozapine and haloperidol, supporting that the disruption of PFC activity is intimately related to the psychotomimetic activity of these agents. Overall, the present experimental model can be successfully used to elucidate the neurobiological basis of schizophrenia symptoms and to examine the potential antipsychotic activity of new drugs in development.


Subject(s)
Behavior, Animal , Brain/physiopathology , Indophenol/analogs & derivatives , Phencyclidine , Prefrontal Cortex/physiopathology , Schizophrenia/chemically induced , Schizophrenic Psychology , Thalamic Nuclei/physiopathology , Animals , Antipsychotic Agents/pharmacology , Behavior, Animal/drug effects , Brain/drug effects , Brain/metabolism , Disease Models, Animal , Humans , Prefrontal Cortex/drug effects , Prefrontal Cortex/metabolism , Schizophrenia/drug therapy , Schizophrenia/metabolism , Schizophrenia/physiopathology , Thalamic Nuclei/drug effects , Thalamic Nuclei/metabolism
15.
Rhinology ; 51(2): 154-61, 2013 Jun.
Article in English | MEDLINE | ID: mdl-23671896

ABSTRACT

BACKGROUND: Extracellular matrix (ECM) proteins such as fibronectin and collagen III, enzymes such as matrix metalloproteinases and macrophages have been demonstrated to intervene in nasal and paranasal sinuses wound healing. AIM OF THE STUDY: To compare concentration of ECM proteins, enzymes and the recruitment of macrophages during wound repair after monopolar electrocautery in contrast with ultrasound submucosal surgical tissue reduction of inferior nasal turbinate (INT) tested in sheep. MATERIALS AND METHODS: Prospective controlled study in sheep. Immunostaining for collagen III, fibronectin, CD68 and matrix metalloproteinase-9 (MMP9) was applied in tissue specimens of INT mucosa after monopolar electrocoagulation (MEC) and ultrasound tissue reduction (UTR). Twelve INTs were studied 1, 3 and 8 weeks post-operatively in each interventional group (MEC and UTR) and 5 INTs were studied in animals of the control group (without surgery). The immunoreactivity was quantitatively graded between 0% to 100% immunoreactivity by a blinded senior pathologist. RESULTS: At the end of the study period collagen III, fibronectin and MMP9 were increased in both groups compared to the levels of the control group. When compared to control group, CD68 immunoreactivity was found higher in MEC group but not in UTR group. Fibronectin subepithelial immunoreactivity exhibited a substantial negative correlation with mucosal epithelial cell necrosis, a substantial positive correlation with fibrosis in MEC-treated specimens and a significant positive correlation with sinusoid engorgement in UTR-treated specimens. Collagen III tissue immunoreactivity showed a particularly significant negative correlation with sinusoid engorgement in MEC-treated specimens. CONCLUSION: Correlation of fibronectin and collagen III immunoreactivity to histopathologic findings suggests different ECM repair processes between MEC and UTR turbinate tissue reduction. The use of CD68 and MMP9 provides additional clues to the mode of actions of these techniques and to the molecular and cellular events of the nasal mucosa wound healing process.


Subject(s)
Electrocoagulation , Immunoenzyme Techniques/methods , Nasal Mucosa/surgery , Turbinates/surgery , Wound Healing/physiology , Analysis of Variance , Animals , Antigens, CD/metabolism , Antigens, Differentiation, Myelomonocytic/metabolism , Collagen/metabolism , Female , Fibronectins/metabolism , Matrix Metalloproteinase 9/metabolism , Nasal Mucosa/metabolism , Prospective Studies , Sheep, Domestic , Statistics, Nonparametric , Turbinates/metabolism , Ultrasonic Therapy
16.
Insect Biochem Mol Biol ; 42(7): 455-65, 2012 Jul.
Article in English | MEDLINE | ID: mdl-22465149

ABSTRACT

The cys-loop ligand-gated ion channel (cysLGIC) super family of Tetranychus urticae, the two-spotted spider mite, represents the largest arthropod cysLGIC super family described to date and the first characterised one within the group of chelicerates. Genome annotation, phylogenetic analysis and comparison of the cysLGIC subunits with their counterparts in insects reveals that the T. urticae genome encodes for a high number of glutamate- and histamine-gated chloride channel genes (GluCl and HisCl) compared to insects. Three orthologues of the insect γ-aminobutyric acid (GABA)-gated chloride channel gene Rdl were detected. Other cysLGIC groups, such as the nAChR subunits, are more conserved and have clear insect orthologues. Members of cysLGIC family mediate endogenous chemical neurotransmission and they are prime targets of insecticides. Implications for toxicology associated with the identity and specific features of T. urticae family members are discussed. We further reveal the accumulation of known and novel mutations in different GluCl channel subunits (Tu_GluCl1 and Tu_GluCl3) associated with abamectin resistance in T. urticae, and provide genetic evidence for their causality. Our study provides useful toxicological insights for the exploration of the T. urticae cysLGIC subunits as putative molecular targets for current and future chemical control strategies.


Subject(s)
Acaricides/pharmacology , Arthropod Proteins/genetics , Cysteine Loop Ligand-Gated Ion Channel Receptors/genetics , Ivermectin/analogs & derivatives , Tetranychidae/drug effects , Tetranychidae/genetics , Amino Acid Sequence , Animals , Arthropod Proteins/chemistry , Arthropod Proteins/metabolism , Base Sequence , Chloride Channels/chemistry , Chloride Channels/genetics , Cysteine Loop Ligand-Gated Ion Channel Receptors/chemistry , Cysteine Loop Ligand-Gated Ion Channel Receptors/metabolism , Drug Resistance , Insect Proteins/chemistry , Insect Proteins/genetics , Insect Proteins/metabolism , Insecta/genetics , Insecta/metabolism , Ivermectin/pharmacology , Molecular Sequence Annotation , Molecular Sequence Data , Multigene Family , Mutation , Phylogeny , Polymerase Chain Reaction , Protein Subunits/chemistry , Protein Subunits/genetics , Protein Subunits/metabolism , Sequence Alignment , Tetranychidae/classification , Tetranychidae/metabolism
17.
Int J Otolaryngol ; 2011: 709469, 2011.
Article in English | MEDLINE | ID: mdl-21837242

ABSTRACT

Background. This study is a review of the incidence, clinical characteristics, and management of secondary BPPV. The different subtypes of secondary BPPV are compared to each other, as well as idiopathic BPPV. Furthermore, the study highlights the coexistence of BPPV with other inner ear pathologies. Methods. A comprehensive search for articles including in the abstract information on incidence, clinical characteristics, and management of secondary BPPV was conducted within the PubMed library. Results. Different referral patterns, different diagnostic criteria used for inner ear diseases, and different patient populations have led to greatly variable incidence results. The differences regarding clinical characteristics and treatment outcomes may support the hypothesis that idiopathic BPPV and the various subtypes of secondary BPPV do not share the exact same pathophysiological mechanisms. Conclusions. Secondary BPPV is often under-diagnosed, because dizziness may be atypical and attributed to the primary inner ear pathology. Reversely, a limited number of BPPV patients may not be subjected to a full examination and characterized as idiopathic, while other inner ear diseases are underdiagnosed. A higher suspicion index for the coexistence of BPPV with other inner ear pathologies, may lead to a more integrated diagnosis and consequently to a more efficient treatment of these patients.

18.
Int J Oral Maxillofac Surg ; 40(5): 464-70, 2011 May.
Article in English | MEDLINE | ID: mdl-21237615

ABSTRACT

Congenital retrognathia and glossoptosis characterize isolated Pierre Robin sequence (iPRS); the small mandible and its retracted position cause retrodisplacement of the tongue and reduction of the oropharyngeal airway. These neonates may be affected by airway obstruction, feeding difficulties, failure to thrive, and chronic hypoxaemia. To solve the respiratory problems secondary to glossoptosis, various treatments have been described including prone positioning, a nasopharyngeal tube, glossopexy, and mandibular distraction. Over the last 28 years, the authors have treated 118 neonates and infants affected by iPRS by carrying out traction of the mandible using two parasymphyseal wires, positioned under local anaesthesia. All the procedures were successful, with no major complication. The patients' respiratory problems and apnoea disappeared suddenly after beginning traction.


Subject(s)
Mandible/surgery , Pierre Robin Syndrome/complications , Respiratory Insufficiency/surgery , Traction/methods , Airway Obstruction/etiology , Airway Obstruction/surgery , Bone Wires , Cleft Palate/therapy , Consumer Behavior , Female , Follow-Up Studies , Humans , Infant , Infant, Newborn , Intubation , Intubation, Gastrointestinal , Male , Nasopharynx , Oximetry , Oxygen/blood , Palatal Obturators , Parents/psychology , Prolapse , Prone Position , Respiratory Insufficiency/etiology , Retrognathia/etiology , Retrognathia/surgery , Retrospective Studies , Tongue Diseases/congenital , Treatment Outcome
19.
J Laryngol Otol ; 125(3): 251-7, 2011 Mar.
Article in English | MEDLINE | ID: mdl-21054906

ABSTRACT

OBJECTIVE: To evaluate the correlation between caloric and vestibular evoked myogenic potential test results, initial audiogram data, and early hearing recovery, in patients with idiopathic sudden hearing loss. MATERIALS AND METHODS: One hundred and four patients with unilateral idiopathic sudden hearing loss underwent complete neurotological evaluation. Results for vestibular evoked myogenic potential and caloric testing were compared with patients' initial and final audiograms. RESULTS: Overall, abnormal vestibular evoked myogenic potential responses occurred in 28.8 per cent of patients, whereas abnormal caloric test results occurred in 50 per cent. A statistically significant relationship was found between the type of inner ear lesion and the incidence of profound hearing loss. Moreover, a negative correlation was found between the extent of the inner ear lesion and the likelihood of early recovery. CONCLUSION: In patients with idiopathic sudden hearing loss, the extent of the inner ear lesion tends to correlate with the severity of cochlear damage. Vestibular assessment may be valuable in predicting the final outcome.


Subject(s)
Hearing Loss, Sensorineural/physiopathology , Hearing Loss, Sudden/physiopathology , Recovery of Function , Vestibular Evoked Myogenic Potentials , Age Factors , Anti-Inflammatory Agents/administration & dosage , Audiometry/methods , Caloric Tests/methods , Ear, Inner/pathology , Ear, Inner/physiopathology , Epidemiologic Methods , Female , Hearing Loss, Sensorineural/diagnosis , Hearing Loss, Sensorineural/therapy , Hearing Loss, Sudden/diagnosis , Hearing Loss, Sudden/therapy , Hearing Loss, Unilateral , Humans , Male , Middle Aged , Prednisolone/administration & dosage , Prognosis , Vertigo/physiopathology
20.
J Laryngol Otol ; 123(12): 1325-30, 2009 Dec.
Article in English | MEDLINE | ID: mdl-19646295

ABSTRACT

OBJECTIVE: To evaluate the results of vestibular evoked myogenic potential testing in patients with idiopathic sudden hearing loss, and to correlate these results with the findings of caloric testing, the clinical appearance of vertigo and the influence of age. MATERIALS AND METHODS: Eighty-six patients with unilateral idiopathic sudden hearing loss and 35 healthy controls underwent a standard protocol of neurotological evaluation. Vestibular evoked myogenic potential responses were measured and compared with caloric responses. RESULTS: On the affected side, 30.2 per cent of patients showed abnormal vestibular evoked myogenic potential responses, while 52.3 per cent had abnormal caloric responses. A statistically significant relationship was found between the results of these two tests. A statistically significant relationship was also found between the type of vestibular lesion and the occurrence of vertigo. Advancing age correlated statistically with more extensive labyrinthic lesions. CONCLUSIONS: A combination of vestibular evoked myogenic potential and electronystagmography testing indicated the existence of vestibular involvement in many patients with idiopathic sudden hearing loss. Both tests are necessary in order to obtain a more thorough and in-depth knowledge of the pathophysiology of idiopathic sudden hearing loss.


Subject(s)
Evoked Potentials, Auditory/physiology , Hearing Loss, Sudden/physiopathology , Otolithic Membrane/physiopathology , Semicircular Canals/physiopathology , Vertigo/physiopathology , Adult , Age Factors , Electronystagmography , Female , Humans , Male , Middle Aged , Reference Values , Vestibular Function Tests
SELECTION OF CITATIONS
SEARCH DETAIL
...